和泓服務(06093.HK)2021年純利增加約81%至1.09億元
格隆匯3月31日丨和泓服務(06093.HK)發佈公吿,截至2021年12月31日止年度,公司總收入增加84.4%至約人民幣7.67億元,除所得税後溢利增加約81.0%至約人民幣1.09億元。淨利潤率維持穩定,截至2021年12月31日止年度為14.2%及截至2020年12月31日止年度為14.4%。
截至2021年12月31日,集團在16個省及直轄市的35個城市管理195個物業管理項目,總訂約建築面積達約46.1百萬平方米,較2020年同期的約22.5百萬平方米增加約104.9%。總在管建築面積達約34.0百萬平方米,較2020年同期的約17.9百萬平方米增加約89.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.